CURITY PHARMA S.A. (formerly HEXO MED S.A.)  has received a medical cannabis installation license. The license, issued by the Greek government, will allow CURITY Pharma to establish cultivation, processing and manufacturing facilities in the region of Thessaly, Greece. CURITY Pharma is poised to become a leader in the European cannabis landscape.

CURITY Pharma’s large-scale high-tech greenhouse and world-class EU GMP facilities will be based on a 67,000 square meter (or 721,182 sq. ft.) plot in Larissa, Greece. The new facilities are expected to initially create 150 jobs in the local community which will continue to scale up as CURITY Pharma further expands. Phase 1 construction of the approximately 12,500 square meter facility is expected to begin in Q1 2021.

Related press release: http://www.globenewswire.com/news-release/2019/06/13/1868246/0/en/HEXO-MED-an-affiliate-of-HEXO-Corp-secures-medical-cannabis-license-in-Europe.html